home / stock / tlis / tlis news

TLIS News and Press, Talis Biomedical Corporation From 03/16/22

Stock Information
Company Name: Talis Biomedical Corporation
Stock Symbol: TLIS
Market: NASDAQ
Website: talis.bio
Menu
TLIS TLIS Quote TLIS Short TLIS News TLIS Articles TLIS Message Board
Get TLIS Alerts

News, Short Squeeze, Breakout and More Instantly...
TLIS - NINE, SIF and IMPP among mid-day movers

Gainers: Sonnet BioTherapeutics Holdings (NASDAQ:SONN) +92%. Zhihu (NYSE:ZH) +80%. Kingsoft Cloud (NASDAQ:KC) +74%. KE Holdings (NYSE:BEKE) +61%. Dingdong Limited (NYSE:DDL) +58%. VNET Group (NASDAQ:VNET) +57%. American Rebel (NASDAQ:AREB) +61%. JOYY (NASDAQ:YY) +53%. Chindata Group (NASDAQ:C...
TLIS - Zai Lab, 111 top healthcare gainers; Talis Biomedical, Incannex lead losers' pack

Gainers: Zai Lab (NASDAQ:ZLAB) +27%. 111 (NASDAQ:YI) +26%. LianBio (NASDAQ:LIAN) +22%. BeiGene BGNE +20%. Palisade Bio PALI +10%. Losers: Talis Biomedical (NASDAQ:TLIS) -42%. Incannex Healthcare (NASDAQ:IXHL) -32%. NLS Pharmaceutics NLSP&...

TLIS - Talis Biomedical Corporation (TLIS) CEO Rob Kelly on Q4 2021 Results - Earnings Call Transcript

Talis Biomedical Corporation (TLIS) Q4 2021 Earnings Conference Call March 15, 2022 16:30 ET Corporate Participants Emily Faucette - Senior Vice President-Corporate Communications and Investor Relations Rob Kelly - Chief Executive Officer Roger Moody - Chief Financial Officer Conference Call ...

TLIS - Talis Biomedical Corporation (TLIS) Q4 2021 Earnings Call Transcript

Image source: The Motley Fool. Talis Biomedical Corporation (NASDAQ: TLIS) Q4 2021 Earnings Call Mar 15, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: Talis Biomedical Corporation (TLIS) Q4 2021 Earnings Call Tran...
TLIS - Talis Biomedical net loss of $28.65M, revenue of $0.86M misses by $0.47M

Talis Biomedical press release (NASDAQ:TLIS): Q4 Net loss of $28.65M. Revenue of $0.86M (+273.9% Y/Y) misses by $0.47M. For further details see: Talis Biomedical net loss of $28.65M, revenue of $0.86M misses by $0.47M

TLIS - Talis Biomedical Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results

MENLO PARK, Calif., March 15, 2022 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care, today provided a business ...

TLIS - TLIS 6-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Talis Biomedical Corporation (TLIS) Investors with Losses to Contact Firm's Attorneys Before Mar. 8th Deadline

San Francisco, California--(Newsfile Corp. - March 2, 2022) - Hagens Berman urges Talis Biomedical Corporation (NASDAQ: TLIS) investors with significant losses to submit your losses now . A securities class action has been filed concerning defendants' representations during Talis' Feb. 2021...
TLIS - Talis Biomedical to Announce Fourth Quarter and Full Year Financial Results on March 15, 2022

MENLO PARK, Calif., March 01, 2022 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation ("TLIS"), a company dedicated to advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care, today announced that it will rep...

TLIS - NOTICE For Investors In NASDAQ: TLIS: Deadline in Lawsuit Against Talis Biomedical Corporation Announced by Shareholders Foundation

San Diego, California--(Newsfile Corp. - March 1, 2022) - The Shareholders Foundation, Inc. announced that a deadline is coming up in the lawsuit that was filed for certain investors in NASDAQ: TLIS shares. Investors who lost a substantial amount in shares of Talis Biomedical Corporation (NAS...

TLIS - TLIS 8-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Talis Biomedical Corporation (TLIS) Investors with Losses to Contact Firm's Attorneys Before Mar. 8th Deadline

SAN FRANCISCO, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Talis Biomedical Corporation (NASDAQ: TLIS) investors with significant losses to submit your losses now .   A securities class action has been filed concerning defendants’ representations during Ta...
Previous 10 Next 10